Exosomes.Cell-to-cell communication, amplified.
Exosomes carry the instructions for repair. The treatment is a matter of delivering those instructions at scale.
- Session length
- 45-60 minutes
- Course
- 1-3 sessions (assessed at consultation)
- Results read
- From 4 weeks, building over 3 months
- Downtime
- Redness 12-24 hours
Exosome therapy is an advanced regenerative injectable treatment that delivers concentrated cell-signalling particles into the skin to stimulate repair, collagen synthesis, and anti-inflammatory processes, offered at Skin Aesthetics by Krystian in Bursledon, Southampton in appointments of 45 to 60 minutes, with results building from four weeks and continuing to develop over three months, minimal downtime for most patients, and suiting those looking for meaningful skin quality improvement, repair after skin damage, or hair loss treatment and who want the consistency and potency of a standardised laboratory preparation rather than an autologous product.
Pricing and booking are on Fresha, kept in one place so it is always current.
Signalling particles. At the frontier of regenerative medicine.
Exosomes are extracellular vesicles, tiny membrane-enclosed particles released by cells as a means of communicating with neighbouring cells. They carry a cargo of proteins, lipids, and genetic material, including messenger RNA and microRNA, that instruct the receiving cell to change its behaviour. In the context of tissue repair, exosomes derived from stem cells or other regenerative cell lines carry signals that tell fibroblasts to produce more collagen and elastin, that direct anti-inflammatory pathways, and that promote angiogenesis, the formation of new blood vessels to support tissue health. The treatment introduces these signalling particles at a concentration far greater than the skin would ordinarily receive, producing a regenerative response that goes beyond what topical skincare or conventional injectables can achieve.
The key difference between exosome therapy and autologous platelet treatments such as PRP or PRF is consistency and concentration. Platelet therapies depend on the patient's own platelet count and health status, which introduces variability from session to session and from patient to patient. Exosome preparations used in clinical aesthetics are manufactured under controlled laboratory conditions, standardised to a known concentration of vesicles and a validated cargo profile. This means the biological signal delivered is consistent, potent, and not subject to the fluctuations associated with individual blood quality.
The science behind the signal. Why exosomes outperform simple growth factor products.
Many regenerative products on the market deliver isolated growth factors, individual proteins with a specific function. Exosomes deliver an entire biological communication package: hundreds of distinct signalling molecules working together in the same way cells use to coordinate complex tissue repair. This cooperative signalling is thought to be why exosome therapy produces a broader and more sustained regenerative response than single-growth-factor preparations, reflecting the way tissue repair actually works biologically rather than providing only one piece of a complex process.
Krystian uses only exosome preparations from suppliers with documented manufacturing standards, peer-reviewed supporting data, and transparent sourcing. This is an area where the quality of the preparation varies enormously between products, and the clinical outcome reflects that quality directly. The consultation will include a discussion of the specific preparation being used, why it was selected, and what the evidence base for it supports.
Exosome therapy is appropriate for patients looking for meaningful improvement in skin quality and density, for those managing the skin consequences of environmental damage, for patients who have not achieved their expected response from platelet therapies, or for those seeking a potent initial stimulus before maintenance with PRP or PRF. It is also offered for scalp treatment in the context of hair thinning, where the anti-inflammatory and follicle-stimulating signals carried by exosomes have demonstrated value in clinical studies. A single session can produce a noticeable result, though a course of three is recommended for significant or established concerns.
Three things discussed before treatment.
Preparation quality, patient suitability, and the current evidence base are all covered transparently at consultation.
Preparation quality and sourcing
Not all exosome products are equivalent. The concentration of vesicles, the cell source, the manufacturing process, and the storage conditions all affect the biological activity of the preparation at the time of use. Krystian discusses the specific preparation used at consultation and will not introduce a product into the treatment menu without reviewing the available evidence and manufacturing documentation. Patients are entitled to ask about sourcing and should be cautious of providers who cannot answer these questions clearly.
The right patient for exosome therapy
Exosome therapy is most appropriate for patients whose primary concern is skin quality, density, and repair rather than volume or structural change. It suits those with environmental or lifestyle-related skin damage, those managing early ageing changes, and those who want a potent regenerative protocol. It is not a treatment for volume loss or facial contouring, and Krystian will direct patients with those concerns toward the appropriate treatment rather than positioning exosomes as a universal solution.
Regulatory and evidence context
Exosome therapy is an emerging treatment area with a growing but still developing evidence base. It is not a licensed medical procedure in the way that some established treatments are, and Krystian will be transparent about the current state of the evidence at consultation, including what is well-established, what is still being studied, and what claims are not yet supported by robust clinical data. Patients should expect an honest assessment of where the science sits, not an oversimplification.
Fifty considered minutes, preparation to placement.
The session is straightforward in process; the depth is in the preparation quality and the precision of delivery.
Arrival and consent
Medical history is reviewed and consent confirmed. Clinical photographs are taken. The treatment plan is confirmed and any questions about the preparation or process are addressed before the session proceeds.
Skin preparation
The treatment area is cleansed thoroughly. Where topical numbing is being used, it is applied and allowed the full recommended time to take effect. The exosome preparation is removed from temperature-controlled storage and allowed to reach the appropriate temperature for use.
Delivery
The exosome preparation is introduced into the skin using microinjection, microneedling, or a combination of both, depending on the area being treated and the protocol agreed at consultation. Microneedling improves dermal penetration of the preparation significantly and is the preferred delivery method for full-face and scalp protocols.
Review and aftercare
The treated area is reviewed and a calming topical applied where appropriate. Aftercare is given clearly in verbal and written form, with specific guidance on sun protection in the following days. The follow-up schedule is confirmed before you leave.
The honest version.
The questions every patient is too polite to ask out loud. Read at your pace.
What are exosomes, and are they safe?
Exosomes are particles produced naturally by cells to communicate with and instruct other cells; they are a fundamental part of how the body coordinates repair and maintenance. In clinical aesthetics, they are prepared from verified cell sources under laboratory conditions and introduced into the skin to amplify the regenerative signals the body would ordinarily send in smaller quantities. The safety profile of high-quality, appropriately sourced exosome preparations is considered good, with no reports of systemic adverse effects in the published clinical literature. Krystian uses only preparations with documented sourcing and manufacturing standards.
How does this compare to PRP or PRF?
PRP and PRF are autologous treatments drawn from your own blood, which means their potency is directly related to your individual platelet count and health status. Exosome preparations are manufactured to a standardised, known concentration, providing a consistent and often higher biological signal than an autologous product can reliably deliver. They also carry a broader cargo of signalling molecules than the growth factors found in platelets alone. For patients who have not achieved the response they expected from platelet therapy, or who want the consistency of a standardised preparation, exosomes are a logical next step.
How many sessions do I need?
One session produces a meaningful result for many patients, and exosome therapy is sometimes used as a single high-potency stimulus before maintenance with a platelet therapy. For significant or established concerns, a course of three sessions provides a more sustained and comprehensive regenerative response. The recommendation is made at consultation based on the specific presentation and the intended outcome.
Is this treatment regulated?
Exosome therapy is an emerging field, and the regulatory landscape is still developing. Krystian will discuss the current evidence base and regulatory context honestly at consultation, including what is well-supported by clinical data and where the science is still evolving. The preparation used is sourced from a supplier with documented manufacturing standards. Patients should expect full transparency on this, and any provider who overstates the regulatory status of exosome therapy should be approached with caution.
Where can I see the pricing?
Pricing and booking are on Fresha. The reserve-your-consultation button on this page takes you directly there.
What we tell you before we begin.
- RednessExpected for 12 to 24 hours post-treatment, typically mild and resolving without intervention.
- Swelling and bruisingPossible at injection points; usually minor and resolving within a few days.
- Preparation variabilityQuality differences between exosome products from different suppliers can affect both the outcome and the safety profile; this is why preparation sourcing is discussed explicitly at consultation.
- Unknown long-term profileExosome therapy is an emerging treatment area; long-term data beyond five years is limited and is presented honestly at consultation.
- ExclusionsPregnancy, breastfeeding, active autoimmune conditions, haematological malignancy or recent oncological treatment, active skin infection in the treatment area, and known allergy to any component of the specific preparation being used.
The complimentary consultation is where Krystian presents the evidence honestly, discusses the preparation being used, and tells you whether this treatment is a good fit for your specific concern and health history.
Reserve your consultation.
If you want to understand what exosome therapy could achieve for your skin and whether it is the right next step given your history and goals, the consultation is where that conversation happens. It is complimentary, held at the clinic in Bursledon, and entirely without obligation.